184
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Bioconversion of aminophosphonates to hydroxyphosphonates via two step redox reactions employing fungi

, , &
Pages 232-238 | Received 15 Jul 2017, Accepted 16 Oct 2017, Published online: 13 Nov 2017
 

GRAPHICAL ABSTRACT

ABSTRACT

The conversion path and the complex procedure of products separation elaborated for ketophosphonates and hydroxyphosphonates formed during the biotransformations of aminophoshonates are reported. Penicillium funiculosum (Thom 3), Geotrichum candidum (6593), Beauveria bassiana (271B) were applied for bioconversion of a racemic mixture of the phosphonic analogue of isoleucine (IleP), whereas P. funiculosum (Thom 3), F. oxysporum (DSM 12646) and Trigonopsis variabilis (DSM 70714) were used for transformation of the phosphonic analogue of valine (ValP). The biocatalytic processes were analysed to confirm and to compare the path and the selectivity of the biological conversion of aminophosphonates with one (ValP) and two stereogenic centers (IleP). The efforts undertaken allowed to demonstrate, that applied biocatalysts act in two steps. A racemic mixture of substrates was bioconverted via oxidative deamination with formation of ketones, which were subsequently bioreduced in the next step of the process. As it was proved the selectivity of the bioreactions differs depending on the structure of the substrate. The first step of the process in the case of the phosphonic analogue of valine 4 allowed to obtain the pure unreacted enantiomer of aminophosphonate (R) whereas the biotransformation of IleP was unselective. Both ketone intermediates were reduced in a non-selective way. The results were evaluated by NMR, MS and IR techniques, which confirmed the path of the biocatalytic two steps redox reaction: oxidation and reduction.

Acknowledgments

This study was financed from the project “Biotransformation for the pharmaceutical and cosmetics industry” no POIG.01.03.01–00–158/09 in part financed by the European Union within the European Regional Development Fund for Innovative Economy.

Additional information

Funding

Biotransformation for the pharmaceutical and cosmetics industry(POIG.01.03.01–00–158/09)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.